Endoglin nucleic acid aptamer based on CRISPR/Cas9 and application
A nucleic acid aptamer and aptamer technology, which is applied in the fields of genetic engineering, immunology and oncology, to achieve the effects of small molecular weight, solving the difficulty of obtaining, and being easy to synthesize and modify
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment
[0029] A kind of Endoglin nucleic acid aptamer and application based on CRISPR / Cas9 of the present invention are realized in the following ways:
[0030] 1. Construction of 293T-CD105 cell line expressing human Endoglin gene
[0031] Using CRISPR / Cas9 technology to insert the pCAG-ENG(cDNA)-pA-PuroR gene into the hAAVS1 site of the human embryonic kidney epithelial cell line 293T cells to construct 293T-CD105 cells stably expressing human Endoglin, and construct an empty vector for transfection 293T cells were used as negative control cells.
[0032] Before screening, it is necessary to investigate the expression of Endoglin protein in target cells and control cells. In the present invention, human CD105-PE antibody is used to incubate target cell 293T-CD105 and control cell 293T, and the expression of Endoglin is identified by flow cytometry. The results are attached figure 1 As shown, the expression level of CD105 protein in 293T-CD105 cells transfected with human Endogli...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com